US
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
Rapid screening of novel therapeutics by ImmuSignature™ T cell activation assay
T cells are critical for cell-mediated immunity and their impaired function correlates with various diseases. Insufficient T cell proliferation and activation can lead to the development of cancer and infectious diseases, while overactivation can result in transplant rejections, autoimmune diseases, and allergies.
This application note describes the development of a robust T cell activation assay to aid assessing the impact of novel therapeutics on T cell function to accelerate drug discovery and development.
For research use only. Not for use in diagnostic procedures.
Download Resource
Rapid screening of novel therapeutics by ImmuSignature™ T cell activation assay